达比加群酯所致急性肝炎 - Suppr

Suppr

超能文献

Dabigatran-induced acute hepatitis.

作者信息

Rochwerg Bram, Xenodemetropoulos Ted, Crowther Mark, Spyropoulos Alex

出版信息

Clin Appl Thromb Hemost. 2012 Sep;18(5):549-50. doi: 10.1177/1076029611435840.

DOI:10.1177/1076029611435840

PMID:22962308

Abstract

摘要

相似文献

Dabigatran-induced acute hepatitis.

Clin Appl Thromb Hemost. 2012 Sep;18(5):549-50. doi: 10.1177/1076029611435840.

Dabigatran: how the drug company withheld important analyses.

BMJ. 2014 Jul 23;349:g4670. doi: 10.1136/bmj.g4670.

The trouble with dabigatran.

BMJ. 2014 Jul 23;349:g4681. doi: 10.1136/bmj.g4681.

Dabigatran, bleeding, and the regulators.

BMJ. 2014 Jul 23;349:g4517. doi: 10.1136/bmj.g4517.

Gastrointestinal bleeding under dabigatran.

J Postgrad Med. 2014 Apr-Jun;60(2):192-3. doi: 10.4103/0022-3859.132343.

Concerns over data in key dabigatran trial.

BMJ. 2014 Jul 23;349:g4747. doi: 10.1136/bmj.g4747.

Dabigatran overdose secondary to acute kidney injury and amiodarone use.

N Z Med J. 2013 Mar 1;126(1370):110-2.

CHA2DS2-VASc and HAS-BLED scores and activated partial thromboplastin time for prediction of high plasma concentration of dabigatran at trough.

Thromb Res. 2015 Jan;135(1):62-7. doi: 10.1016/j.thromres.2014.10.025. Epub 2014 Nov 4.

Dabigatran-associated spontaneous acute cervical epidural hematoma.

World Neurosurg. 2015 Feb;83(2):257-8. doi: 10.1016/j.wneu.2014.10.012. Epub 2014 Oct 16.

Agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation.

Intern Med. 2012;51(15):1987-90. doi: 10.2169/internalmedicine.51.7601. Epub 2012 Aug 1.

引用本文的文献

Liver injury from direct oral anticoagulants.

World J Hepatol. 2023 Jun 27;15(6):841-849. doi: 10.4254/wjh.v15.i6.841.

Rhabdomyolysis happened after the start of dabigatran etexilate treatment: A case report.

J Musculoskelet Neuronal Interact. 2022 Jun 1;22(2):296-300.

Dabigatran must be used carefully: literature review and recommendations for management of adverse events.

Drug Des Devel Ther. 2019 May 6;13:1527-1533. doi: 10.2147/DDDT.S203112. eCollection 2019.

Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis.

Drug Saf. 2018 Sep;41(9):881-897. doi: 10.1007/s40264-018-0668-9.

Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation.

Heart. 2017 Jun;103(11):834-839. doi: 10.1136/heartjnl-2016-310586. Epub 2017 Jan 5.

Dabigatran overdose: a case report of acute hepatitis. Extracorporeal treatment.

Int J Hematol. 2017 Apr;105(4):532-535. doi: 10.1007/s12185-016-2158-0. Epub 2016 Dec 1.

Hepatotoxicity of New Oral Anticoagulants (NOACs).

Drug Saf. 2015 Aug;38(8):711-20. doi: 10.1007/s40264-015-0317-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Dabigatran-induced acute hepatitis.

Clin Appl Thromb Hemost. 2012 Sep;18(5):549-50. doi: 10.1177/1076029611435840.

Dabigatran: how the drug company withheld important analyses.

BMJ. 2014 Jul 23;349:g4670. doi: 10.1136/bmj.g4670.

The trouble with dabigatran.

BMJ. 2014 Jul 23;349:g4681. doi: 10.1136/bmj.g4681.

Dabigatran, bleeding, and the regulators.

BMJ. 2014 Jul 23;349:g4517. doi: 10.1136/bmj.g4517.

Gastrointestinal bleeding under dabigatran.

J Postgrad Med. 2014 Apr-Jun;60(2):192-3. doi: 10.4103/0022-3859.132343.

Concerns over data in key dabigatran trial.

BMJ. 2014 Jul 23;349:g4747. doi: 10.1136/bmj.g4747.

Dabigatran overdose secondary to acute kidney injury and amiodarone use.

N Z Med J. 2013 Mar 1;126(1370):110-2.

CHA2DS2-VASc and HAS-BLED scores and activated partial thromboplastin time for prediction of high plasma concentration of dabigatran at trough.

Thromb Res. 2015 Jan;135(1):62-7. doi: 10.1016/j.thromres.2014.10.025. Epub 2014 Nov 4.

Dabigatran-associated spontaneous acute cervical epidural hematoma.

World Neurosurg. 2015 Feb;83(2):257-8. doi: 10.1016/j.wneu.2014.10.012. Epub 2014 Oct 16.

Agranulocytosis immediately after oral administration of cibenzoline and dabigatran in a patient with paroxysmal atrial fibrillation.

Intern Med. 2012;51(15):1987-90. doi: 10.2169/internalmedicine.51.7601. Epub 2012 Aug 1.

引用本文的文献

Liver injury from direct oral anticoagulants.

World J Hepatol. 2023 Jun 27;15(6):841-849. doi: 10.4254/wjh.v15.i6.841.

Rhabdomyolysis happened after the start of dabigatran etexilate treatment: A case report.

J Musculoskelet Neuronal Interact. 2022 Jun 1;22(2):296-300.

Dabigatran must be used carefully: literature review and recommendations for management of adverse events.

Drug Des Devel Ther. 2019 May 6;13:1527-1533. doi: 10.2147/DDDT.S203112. eCollection 2019.

Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis.

Drug Saf. 2018 Sep;41(9):881-897. doi: 10.1007/s40264-018-0668-9.

Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation.

Heart. 2017 Jun;103(11):834-839. doi: 10.1136/heartjnl-2016-310586. Epub 2017 Jan 5.

Dabigatran overdose: a case report of acute hepatitis. Extracorporeal treatment.

Int J Hematol. 2017 Apr;105(4):532-535. doi: 10.1007/s12185-016-2158-0. Epub 2016 Dec 1.

Hepatotoxicity of New Oral Anticoagulants (NOACs).

Drug Saf. 2015 Aug;38(8):711-20. doi: 10.1007/s40264-015-0317-5.